New cochlear implants aim to sharpen hearing for adults

NCT ID NCT07338864

Not yet recruiting Disease control Sponsor: Cochlear Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test three new types of cochlear implants in 66 adults with severe hearing loss. The goal is to see if the implants improve speech understanding and overall hearing quality. Participants will receive the implant as part of their normal care, and researchers will track their progress over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cochlear implant device (Nucleus Nexa CI1032, CI1022, or CI1012)
What this could lead to
If successful, this could confirm that newer cochlear implants provide better speech understanding and hearing quality for adults with severe hearing loss.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. It is also small (66 people) and not yet recruiting, so findings may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING IMPLANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Düsseldorf

    Düsseldorf, 40225, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.